Carla H van Gils
Overview
Explore the profile of Carla H van Gils including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
249
Citations
7160
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wang H, H M van der Velden B, Verburg E, Bakker M, Pijnappel R, Veldhuis W, et al.
Radiology
. 2023 Aug;
308(2):e222841.
PMID: 37552061
Background Automated identification of quantitative breast parenchymal enhancement features on dynamic contrast-enhanced (DCE) MRI scans could provide added value in assessment of breast cancer risk in women with extremely dense...
12.
El Sharouni M, Lo S, Scolyer R, van Gils C, Thompson J
J Am Acad Dermatol
. 2023 Mar;
89(2):e97-e98.
PMID: 36935017
No abstract available.
13.
Helsper C, van Gils C, Van Erp N, Siepman van den Berg M, Rogouti O, van Asselt K, et al.
Cancers (Basel)
. 2023 Mar;
15(5).
PMID: 36900257
The Coronavirus disease 2019 (COVID-19) outbreak impacted health care. We investigated its impact on the time to referral and diagnosis for symptomatic cancer patients in The Netherlands. We performed a...
14.
Song C, van Gils C, Yip C, Soerjomataram I, Taib N, See M, et al.
Diagnostics (Basel)
. 2023 Feb;
13(4).
PMID: 36832162
(1) Background: Differences in access to biomarker testing and cancer treatment in resource-limited settings may affect the clinical utility of the AJCC8 staging system compared to the anatomical AJCC7 system....
15.
El Sharouni M, Lo S, Varey A, Elias S, Witkamp A, Sigurdsson V, et al.
Future Oncol
. 2023 Feb;
19(2):97-102.
PMID: 36762595
What Is This Summary About?: This is a summary of an article describing the development of risk calculators for use in people who develop a type of melanoma on their...
16.
Siepman van den Berg M, Grant M, van Erp N, van Gils C, Muris J, Brandenbarg D, et al.
J Gen Fam Med
. 2023 Jan;
PMID: 36718286
Background: To describe general practitioners (GPs) experiences with the impact COVID-19 on the duration of cancer detection. Methods: Cross-sectional survey study among Dutch GPs. Results: Fifty-eight GPs participated. During the...
17.
El Sharouni M, Rawson R, Potter A, Paver E, Wilmott J, Witkamp A, et al.
J Am Acad Dermatol
. 2022 Dec;
88(3):609-616.
PMID: 36509217
Background: Melanomas in the first 2 decades of life are uncommon and poorly understood. Objective: To assess clinicopathologic features and survival of children (≤11 years) and adolescents (12-19 years) diagnosed...
18.
Grant M, Helsper C, Stellato R, van Erp N, van Asselt K, Slottje P, et al.
Cancers (Basel)
. 2022 Nov;
14(21).
PMID: 36358772
In the Netherlands, the onset of the coronavirus pandemic saw shifts in primary health service provision away from physical consultations, cancer-screening programs were temporarily halted, and government messaging focused on...
19.
Comert D, van Gils C, Veldhuis W, Mann R
J Magn Reson Imaging
. 2022 Nov;
57(3):706-726.
PMID: 36349728
Since four decades mammography is used for early breast cancer detection in asymptomatic women and still remains the gold standard imaging modality. However, population screening programs can be personalized and...
20.
Verburg E, van Gils C, H M van der Velden B, Bakker M, Pijnappel R, Veldhuis W, et al.
Invest Radiol
. 2022 Oct;
58(4):293-298.
PMID: 36256783
Objectives: Computer-aided triaging (CAT) and computer-aided diagnosis (CAD) of screening breast magnetic resonance imaging have shown potential to reduce the workload of radiologists in the context of dismissing normal breast...